Cilostazol after PCI in patients with acute coronary syndrome platelet aggregation.docVIP

 PAGE \* MERGEFORMAT 6 Cilostazol after PCI in patients with acute coronary syndrome platelet aggregation [Abstract] Objective To investigate the cilostazol after PCI in patients with acute coronary syndrome platelet aggregation. Method has been diagnosed with acute coronary syndrome, elective surgery successful PCI were randomly divided into cilostazol group and control group. All patients were regular aspirin and clopidogrel antiplatelet therapy, cilostazol group was plus cilostazol 200mg / d, after 24h and 30 days measured by the ADP-induced platelet aggregation. The results of platelet aggregation in cilostazol group was significantly lower than the control group, the difference was significant. 30 days after surgery between the two groups major adverse cardiac events (death, acute myocardial infarction, target vessel revascularization) and bleeding events not a significant difference in the occurrence, but in the cilostazol group of thrombotic events decreased. Conclusion combination of cilostazol on PCI in patients with acute coronary syndrome patients have a more significant platelet aggregation inhibition. [Keywords:] Cilostazol; acute coronary syndrome; platelet aggregation Overseas studies have shown that early intervention with enhanced anti-platelet therapy can significantly benefit patients, the clinical application of the current anti-platelet solution is combined aspirin and clopidogrel. This study aimed to explore further combined with cilostazol azole in patients with acute coronary syndrome after PCI platelet aggregation. 1 Clinical data 1.1 General information on selected hospital in June 2007 -2009 diagnosed in February with acute coronary syndrome, non-PCI contraindications, elective surgery patients successful PCI 160 cases were randomly divided into the cilostazol group and 80 control group cases. 1.2 method two groups in gender, age, past medical history and so the difference was not statistically significant. Cilostazo